G47.41

Clinical Causes: Genetic predisposition, particularly the association with certain human leukocyte antigen (HLA) alleles Loss of hypocretin-producing neurons in the hypothalamus, which regulate wakefulness and REM sleep Autoimmune responses that mistakenly target hypocretin-producing cells Environmental triggers, such as infections or stress, which may precipitate symptoms in genetically predisposed individuals Other factors like brain injury or tumors affecting sleep regulation centers

Key Symptoms: Excessive daytime sleepiness, often persistent and overwhelming Cataplexy — sudden muscle weakness or loss of muscle tone triggered by strong emotions Sleep paralysis — temporary inability to move or speak while falling asleep or waking Hallucinations during the transition between sleep and wakefulness Disrupted nighttime sleep, including frequent awakenings Automatic behaviors — performing tasks unconsciously during sleep episodes

Diagnosis Path: Multiple Sleep Latency Test (MSLT) — measures how quickly a person falls asleep during the day and identifies REM sleep episodes Polysomnography — a comprehensive sleep study conducted overnight to monitor sleep patterns and disturbances Blood tests — to rule out other conditions and assess hypocretin levels, when available Evaluation of symptoms and medical history to identify characteristic features

Treatment Protocols: Medications such as stimulants to promote wakefulness during the day Antidepressants to reduce cataplexy, hallucinations, and sleep paralysis Scheduled napping — planned short naps during the day to reduce sleepiness Sleep hygiene practices — maintaining a regular sleep schedule and creating a sleep-conducive environment Lifestyle adjustments — managing stress, avoiding alcohol and caffeine close to bedtime, and ensuring a safe sleep environment